Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
Type of securities : Common share | Effective Date : 19/10/2021 | Close Selling Date : 26/10/2021
Facebook page “TCP Group” impersonates “T.C. Pharmaceutical Industries Co., Ltd.” : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)
Market Supervisory Board No. TorThor/Khor/Dor/Nor. 62/2552 Re. Determination for Securities Companies to Proceed with Customer Complaints ______________________ By virtue of Section 16/6 and Section 113 of
Calling for the Shareholders' Meeting of the Company that has changed its purpose of using funds according to the information disclosure form of securities offering and draft prospectus to proceed with 1
. Distribution Cost and Proceed to fund The Company incurred distribution cost and proceed to fund at THB 497 million compare to THB 374 million previous year. An increase mainly came from proceed to fund, since
invest in such products should proceed with extra caution since:(1) The product above has not been screened with regard to its qualifications and smart contracts by SEC-approved ICO portals; (2